Syntis Bio
Milton, MA
Syntis Bio operates as a late-stage preclinical company intended to develop a new class of therapy. The company's drug uses novel formulations for oral therapies that target specific tissues, enabling users to increase bioavailability.
syntis.bioCompany Details
Founded
- 2022
Employees
- Between 5 - 20 employees
Raised
- $15,372,179
Headquarters Location
- Milton, MA
Public
- No
Acquired
- No
CEO
Rahul Dhanda
Founders
- Giovanni TraversoRahul Dhanda
Company Collections
These are collections Syntis Bio is a part of. Click on the collection name to view similar companies.